SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-015590
Filing Date
2022-04-22
Accepted
2022-04-22 16:31:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20003930x2_defa14a.htm DEFA14A 7150
2 ny20003930x2_nc01.jpg GRAPHIC 782025
3 ny20003930x2_nc02.jpg GRAPHIC 425410
  Complete submission text file 0001140361-22-015590.txt   1631115
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38981 | Film No.: 22845994
SIC: 2834 Pharmaceutical Preparations